[1] |
|
[2] |
Lee TY, Lee SH, Cheon YK, et al. The comparison of clinical outcomes in elderly (≥75 years) and non-elderly (<75 years) patients with acute cholangitis due to choledocholithiasis[J]. Medicina, 2023, 59(12): 2171. DOI: 10.3390/medicina59122171.
|
[3] |
Zhang Z, Zhao Y, Lin F, et al. Protective and therapeutic experience of perioperative safety in extremely elderly patients with biliary diseases[J]. Medicine, 2021, 100(21): e26159. DOI: 10.1097/MD.0000000000026159.
|
[4] |
Loozen CS, van Ramshorst B, van Santvoort HC, et al. Early cholecystectomy for acute cholecystitis in the elderly population: a systematic review and meta-analysis[J]. Dig Surg, 2017, 34(5): 371-379. DOI: 10.1159/000455241.
|
[5] |
|
[6] |
|
[7] |
World Health Organization. WHO handbook for guideline development, 2nd ed[M/OL]. Geneva: World Health Organization, 2014[2024-12-15].
URL
|
[8] |
Chen Y, Yang K, Marušic A, et al. A reporting tool for practice guidelines in health care: the RIGHT statement[J]. Ann Intern Med, 2017, 166(2): 128-132. DOI: 10.7326/M16-1565.
|
[9] |
Shea BJ, Reeves BC, Wells G, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both[J]. BMJ, 2017, 358: j4008. DOI: 10.1136/bmj.j4008.
|
[10] |
Bossuyt PM, Deeks JJ, Leeflang MM, et al. Evaluating medical tests: introducing the cochrane handbook for systematic reviews of diagnostic test accuracy[J]. Cochrane Database Syst Rev, 2023, 7(7): ED000163. DOI: 10.1002/14651858.ED000163.
|
[11] |
Wells G, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses[Z]. Ottawa Hospital Research Institute, 2014.
|
[12] |
Whiting PF, Rutjes AWS, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies[J]. Ann Intern Med, 2011, 155(8): 529-536. DOI: 10.7326/0003-4819-155-8-201110180-00009.
|
[13] |
Whiting P, Savović J, Higgins JPT, et al. ROBIS: a new tool to assess risk of bias in systematic reviews was developed[J]. J Clin Epidemiol, 2016, 69: 225-234. DOI: 10.1016/j.jclinepi.2015.06.005.
|
[14] |
Guyatt GH, Alonso-Coello P, Schünemann HJ, et al. Guideline panels should seldom make good practice statements: guidance from the GRADE Working Group[J]. J Clin Epidemiol, 2016, 80: 3-7. DOI: 10.1016/j.jclinepi.2016.07.006.
|
[15] |
Yokoe M, Takada T, Strasberg SM, et al. TG13 diagnostic criteria and severity grading of acute cholecystitis (with videos)[J]. J Hepatobiliary Pancreat Sci, 2013, 20(1): 35-46. DOI: 10.1007/s00534-012-0568-9.
|
[16] |
Yokoe M, Hata J, Takada T, et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos)[J]. J Hepatobiliary Pancreat Sci, 2018, 25(1): 41-54. DOI: 10.1002/jhbp.515.
|
[17] |
Ansaloni L, Pisano M, Coccolini F, et al. Erratum to: 2016 WSES guidelines on acute calculous cholecystitis[J]. World J Emerg Surg, 2016, 11: 52. DOI: 10.1186/s13017-016-0088-z.
|
[18] |
Pisano M, Allievi N, Gurusamy K, et al. 2020 World Society of Emergency Surgery updated guidelines for the diagnosis and treatment of acute Calculus cholecystitis[J]. World J Emerg Surg, 2020, 15(1): 61. DOI: 10.1186/s13017-020-00336-x.
|
[19] |
Yokoe M, Takada T, Strasberg SM, et al. New diagnostic criteria and severity assessment of acute cholecystitis in revised Tokyo Guidelines[J]. J Hepatobiliary Pancreat Sci, 2012, 19(5): 578-585. DOI: 10.1007/s00534-012-0548-0.
|
[20] |
Naidu K, Beenen E, Gananadha S, et al. The yield of fever, inflammatory markers and ultrasound in the diagnosis of acute cholecystitis: a validation of the 2013 Tokyo guidelines[J]. World J Surg, 2016, 40(12): 2892-2897. DOI: 10.1007/s00268-016-3660-5.
|
[21] |
Sanson TG, O’Keefe KP. Evaluation of abdominal pain in the elderly[J]. Emerg Med Clin North Am, 1996, 14(3): 615-627. DOI: 10.1016/s0733-8627(05)70270-4.
|
[22] |
Ragsdale L, Southerland L. Acute abdominal pain in the older adult[J]. Emerg Med Clin North Am, 2011, 29(2): 429-448, x. DOI: 10.1016/j.emc.2011.01.012.
|
[23] |
Hafif A, Gutman M, Kaplan O, et al. The management of acute cholecystitis in elderly patients[J]. Am Surg, 1991, 57(10): 648-652.
|
[24] |
Kunin N, Letoquart J, La Gamma A, et al. Acute cholecystitis in the elderly[J]. 1994,131(5):257-260.
|
[25] |
Parker LJ, Vukov LF, Wollan PC. Emergency department evaluation of geriatric patients with acute cholecystitis[J]. Acad Emerg Med, 1997, 4(1): 51-55. DOI: 10.1111/j.1553-2712.1997.tb03643.x.
|
[26] |
Van Steenbergen W. Acute and chronic pancreatitis in the elderly patient[J]. Tijdschr Gerontol Geriatr, 1996, 27(5): 191-196.
|
[27] |
Adedeji OA, McAdam WA. Murphy’s sign, acute cholecystitis and elderly people[J]. J R Coll Surg Edinb, 1996, 41(2): 88-89.
|
[28] |
McGillicuddy EA, Schuster KM, Brown E, et al. Acute cholecystitis in the elderly: use of computed tomography and correlation with ultrasonography[J]. Am J Surg, 2011, 202(5): 524-527. DOI: 10.1016/j.amjsurg.2011.06.012.
|
[29] |
Velissaris D, Pantzaris N, Koniari I, et al. C-reactive protein and frailty in the elderly: a literature review[J]. J Clin Med Res, 2017, 9(6): 461-465. DOI: 10.14740/jocmr2959w.
|
[30] |
Kubat M, Şengül S, Şahin S. Efficacy of blood parameters as indicators of the need for overdue urgent cholecystectomy in elderly patients with acute cholecystitis[J]. Ulus Travma Acil Cerrahi Derg, 2023, 29(11): 1248-1254. DOI: 10.14744/tjtes.2023.75670.
|
[31] |
Puzianowska-Kuźnicka M, Owczarz M, Wieczorowska-Tobis K, et al. Interleukin-6 and C-reactive protein, successful aging, and mortality: the PolSenior study[J]. Immun Ageing, 2016, 13: 21. DOI: 10.1186/s12979-016-0076-x.
|
[32] |
|
[33] |
|
[34] |
Kiriyama S, Takada T, Hwang TL, et al. Clinical application and verification of the TG13 diagnostic and severity grading criteria for acute cholangitis: an international multicenter observational study[J]. J Hepatobiliary Pancreat Sci, 2017, 24(6): 329-337. DOI: 10.1002/jhbp.458.
|
[35] |
Hirota M, Takada T, Kawarada Y, et al. Diagnostic criteria and severity assessment of acute cholecystitis: Tokyo Guidelines[J]. J Hepatobiliary Pancreat Surg, 2007, 14(1): 78-82. DOI: 10.1007/s00534-006-1159-4.
|
[36] |
Pettilä V, Pettilä M, Sarna S, et al. Comparison of multiple organ dysfunction scores in the prediction of hospital mortality in the critically ill[J]. Crit Care Med, 2002, 30(8): 1705-1711. DOI: 10.1097/00003246-200208000-00005.
|
[37] |
Gourd NM, Nikitas N. Multiple organ dysfunction syndrome[J]. J Intensive Care Med, 2020, 35(12): 1564-1575. DOI: 10.1177/0885066619871452.
|
[38] |
|
[39] |
Sun G, Han L, Yang Y, et al. Comparison of two editions of Tokyo guidelines for the management of acute cholangitis[J]. J Hepatobiliary Pancreat Sci, 2014, 21(2): 113-119. DOI: 10.1002/jhbp.9.
|
[40] |
Kiewiet JJS, Leeuwenburgh MMN, Bipat S, et al. A systematic review and meta-analysis of diagnostic performance of imaging in acute cholecystitis[J]. Radiology, 2012, 264(3): 708-720. DOI: 10.1148/radiol.12111561.
|
[41] |
Harvey RT, Miller WT Jr. Acute biliary disease: initial CT and follow-up US versus initial US and follow-up CT[J]. Radiology, 1999, 213(3): 831-836. DOI: 10.1148/radiology.213.3.r99dc17831.
|
[42] |
Fuks D, Mouly C, Robert B, et al. Acute cholecystitis: preoperative CT can help the surgeon consider conversion from laparoscopic to open cholecystectomy[J]. Radiology, 2012, 263(1): 128-138. DOI: 10.1148/radiol.12110460.
|
[43] |
Ansaloni L, Pisano M, Coccolini F, et al. 2016 WSES guidelines on acute calculous cholecystitis[J]. World J Emerg Surg, 2016, 11: 25. DOI: 10.1186/s13017-016-0082-5.
|
[44] |
Kaura SH, Haghighi M, Matza BW, et al. Comparison of CT and MRI findings in the differentiation of acute from chronic cholecystitis[J]. Clin Imaging, 2013, 37(4): 687-691. DOI: 10.1016/j.clinimag.2013.02.009.
|
[45] |
Williams EJ, Green J, Beckingham I, et al. Guidelines on the management of common bile duct stones (CBDS)[J]. Gut, 2008, 57(7): 1004-1021. DOI: 10.1136/gut.2007.121657.
|
[46] |
Eun HW, Kim JH, Hong SS, et al. Assessment of acute cholangitis by MR imaging[J]. Eur J Radiol, 2012, 81(10): 2476-2480. DOI: 10.1016/j.ejrad.2011.10.020.
|
[47] |
Singh A, Mann HS, Thukral CL, et al. Diagnostic accuracy of MRCP as compared to ultrasound/CT in patients with obstructive jaundice[J]. J Clin Diagn Res, 2014, 8(3): 103-107. DOI: 10.7860/JCDR/2014/8149.4120.
|
[48] |
|
[49] |
|
[50] |
Ueda T, Kawakami R, Horii M, et al. Noncardiovascular death, especially infection, is a significant cause of death in elderly patients with acutely decompensated heart failure[J]. J Card Fail, 2014, 20(3): 174-180. DOI: 10.1016/j.cardfail.2013.12.007.
|
[51] |
Liu BH, Li YG, Liu JX, et al. Assessing inflammation in Chinese subjects with subtypes of heart failure: an observational study of the Chinese PLA Hospital Heart Failure Registry[J]. J Geriatr Cardiol, 2019, 16(4): 313-319. DOI: 10.11909/j.issn.1671-5411.2019.04.002.
|
[52] |
|
[53] |
|
[54] |
《感染诱发的老年多器官功能障碍综合征诊治中国专家共识》撰写组. 感染诱发的老年多器官功能障碍综合征诊治中国专家共识[J]. 中国实用内科杂志, 2018, 38(8): 727-738. DOI: 10.19538/j.nk2018080109.
|
[55] |
Summary of recommendation statements[J]. Kidney Int Suppl, 2012, 2(1): 8-12. DOI: 10.1038/kisup.2012.7.
|
[56] |
Luo X, Jiang L, Du B, et al. A comparison of different diagnostic criteria of acute kidney injury in critically ill patients[J]. Crit Care, 2014, 18(4): R144. DOI: 10.1186/cc13977.
|
[57] |
Li Z, Cai L, Liang X, et al. Identification and predicting short-term prognosis of early cardiorenal syndrome type 1: KDIGO is superior to RIFLE or AKIN[J]. PLoS One, 2014, 9(12): e114369. DOI: 10.1371/journal.pone.0114369.
|
[58] |
Pereira M, Rodrigues N, Godinho I, et al. Acute kidney injury in patients with severe sepsis or septic shock: a comparison between the 'Risk, Injury, Failure, Loss of kidney function, End-stage kidney disease’ (RIFLE), Acute Kidney Injury Network (AKIN) and Kidney Disease: Improving Global Outcomes (KDIGO) classifications[J]. Clin Kidney J, 2017, 10(3): 332-340. DOI: 10.1093/ckj/sfw107.
|
[59] |
Li Q, Zhao M, Wang X. AKI in the very elderly patients without preexisting chronic kidney disease: a comparison of 48-hour window and 7-day window for diagnosing AKI using the KDIGO criteria[J]. Clin Interv Aging, 2018, 13: 1151-1160. DOI: 10.2147/CIA.S162899.
|
[60] |
Thabit AK. Antibiotics in the biliary tract: a review of the pharmacokinetics and clinical outcomes of antibiotics penetrating the bile and gallbladder wall[J]. Pharmacotherapy, 2020, 40(7): 672-691. DOI: 10.1002/phar.2431.
|
[61] |
Gomi H, Solomkin JS, Schlossberg D, et al. Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis[J]. J Hepatobiliary Pancreat Sci, 2018, 25(1): 3-16. DOI: 10.1002/jhbp.518.
|
[62] |
Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021[J]. Intensive Care Med, 2021, 47(11): 1181-1247. DOI: 10.1007/s00134-021-06506-y.
|
[63] |
|
[64] |
|
[65] |
Zhanel GG, Golden AR, Zelenitsky S, et al. Cefiderocol: a siderophore cephalosporin with activity against carbapenem-resistant and multidrug-resistant gram-negative bacilli[J]. Drugs, 2019, 79(3): 271-289. DOI: 10.1007/s40265-019-1055-2.
|
[66] |
Wen J, Zeng M, Shu Y, et al. Aging increases the susceptibility of cisplatin-induced nephrotoxicity[J]. Age, 2015, 37(6): 112. DOI: 10.1007/s11357-015-9844-3.
|
[67] |
Mayumi T, Okamoto K, Takada T, et al. Tokyo Guidelines 2018: management bundles for acute cholangitis and cholecystitis[J]. J Hepatobiliary Pancreat Sci, 2018, 25(1): 96-100. DOI: 10.1002/jhbp.519.
|
[68] |
|
[69] |
Reuter DA, Kirchner A, Felbinger TW, et al. Usefulness of left ventricular stroke volume variation to assess fluid responsiveness in patients with reduced cardiac function[J]. Crit Care Med, 2003, 31(5): 1399-1404. DOI: 10.1097/01.CCM.0000059442.37548.E1.
|
[70] |
|
[71] |
|
[72] |
He Y, Tang X, Ning N, et al. Effects of preoperative oral electrolyte-carbohydrate nutrition supplement on postoperative outcomes in elderly patients receiving total knee arthroplasty: a prospective randomized controlled trial[J]. Orthop Surg, 2022, 14(10): 2535-2544. DOI: 10.1111/os.13424.
|
[73] |
|
[74] |
Magne H, Savary-Auzeloux I, Rémond D, et al. Nutritional strategies to counteract muscle atrophy caused by disuse and to improve recovery[J]. Nutr Res Rev, 2013, 26(2): 149-165. DOI: 10.1017/S0954422413000115.
|
[75] |
Mukai S, Itoi T, Baron TH, et al. Indications and techniques of biliary drainage for acute cholangitis in updated Tokyo Guidelines 2018[J]. J Hepatobiliary Pancreat Sci, 2017, 24(10): 537-549. DOI: 10.1002/jhbp.496.
|
[76] |
Orouji Jokar T, Ibraheem K, Rhee P, et al. Emergency general surgery specific frailty index: a validation study[J]. J Trauma Acute Care Surg, 2016, 81(2): 254-260. DOI: 10.1097/TA.0000000000001120.
|
[77] |
|
[78] |
Shao X, Cui X. Safety of cholecystectomy in patients under antithrombotic drugs: a systematic review and meta-analysis[J]. Pak J Med Sci, 2022, 38(8): 2365-2372. DOI: 10.12669/pjms.38.8.7032.
|
[79] |
Joseph B, Rawashdeh B, Aziz H, et al. An acute care surgery dilemma: emergent laparoscopic cholecystectomy in patients on aspirin therapy[J]. Am J Surg, 2015, 209(4): 689-694. DOI: 10.1016/j.amjsurg.2014.04.014.
|
[80] |
Noda T, Hatano H, Dono K, et al. Safety of early laparoscopic cholecystectomy for patients with acute cholecystitis undergoing antiplatelet or anticoagulation therapy: a single-institution experience[J]. Hepatogastroenterology, 2014, 61(134): 1501-1506.
|
[81] |
Takahashi R, Fujikawa T. Impact of perioperative aspirin continuation on bleeding complications in laparoscopic colorectal cancer surgery: a propensity score-matched analysis[J]. Surg Endosc, 2021, 35(5): 2075-2083. DOI: 10.1007/s00464-020-07604-6.
|
[82] |
Monden K, Sadamori H, Hioki M, et al. Safety and feasibility of liver resection with continued antiplatelet therapy using aspirin[J]. J Hepatobiliary Pancreat Sci, 2017, 24(7): 375-381. DOI: 10.1002/jhbp.461.
|
[83] |
任静, 惠升奇. 围手术期持续服用抗凝药物对胆囊微创手术出血的疗效观察[J]. 血栓与止血学, 2022, 28(2): 256-257.
|
[84] |
Anderson K, Jupiter DC, Abernathy SW, et al. Should clopidogrel be discontinued before laparoscopic cholecystectomy?[J]. Am J Surg, 2014, 208(6): 926-931; discussion 930-931. DOI: 10.1016/j.amjsurg.2014.08.001.
|
[85] |
Jupiter DC, Fang X, Adhikari D, et al. Safety of continued clopidogrel use in the preoperative course of gastrointestinal surgery: a retrospective cohort study[J]. Ann Surg, 2017, 265(2): 370-378. DOI: 10.1097/SLA.0000000000001726.
|
[86] |
Chu EW, Chernoguz A, Divino CM. The evaluation of clopidogrel use in perioperative general surgery patients: a prospective randomized controlled trial[J]. Am J Surg, 2016, 211(6): 1019-1025. DOI: 10.1016/j.amjsurg.2015.05.036.
|
[87] |
Ercan M, Bostanci EB, Ozer I, et al. Postoperative hemorrhagic complications after elective laparoscopic cholecystectomy in patients receiving long-term anticoagulant therapy[J]. Langenbecks Arch Surg, 2010, 395(3): 247-253. DOI: 10.1007/s00423-009-0483-y.
|
[88] |
Koc U, Bostanci EB, Karaman K, et al. Basic hemostatic parameters in patients with long-term oral anticoagulation undergoing cholecystectomy[J]. J Laparoendosc Adv Surg Tech A, 2011, 21(5): 417-425. DOI: 10.1089/lap.2010.0391.
|
[89] |
Kwok A, Chern TY, Winn R. Acute cholecystitis and gallbladder perforation leading to massive haemoperitoneum in a patient taking rivaroxaban[J]. BMJ Case Rep, 2018, 2018: bcr2018226870. DOI: 10.1136/bcr-2018-226870.
|
[90] |
|
[91] |
|
[92] |
中华医学会外科学分会血管外科学组. 利伐沙班临床应用中国专家建议——深静脉血栓形成治疗分册[J/CD]. 中国血管外科杂志(电子版), 2013, 5(4): 209-213.
|
[93] |
Loozen CS, Oor JE, van Ramshorst B, et al. Conservative treatment of acute cholecystitis: a systematic review and pooled analysis[J]. Surg Endosc, 2017, 31(2): 504-515. DOI: 10.1007/s00464-016-5011-x.
|
[94] |
Markopoulos G, Mulita F, Kehagias D, et al. Outcomes of percutaneous cholecystostomy in elderly patients: a systematic review and meta-analysis[J]. Prz Gastroenterol, 2021, 16(3): 188-195. DOI: 10.5114/pg.2020.100658.
|
[95] |
|
[96] |
Oldani A, Calabrò M, Maroso F, et al. Early surgical management of acute cholecystitis in ultra-octogenarian patients: our 5-year experience[J]. Minerva Chir, 2019, 74(3): 203-206. DOI: 10.23736/S0026-4733.18.07719-2.
|
[97] |
Er S, Berkem H, Özden S, et al. Clinical course of percutaneous cholecystostomies: a cross-sectional study[J]. World J Clin Cases, 2020, 8(6): 1033-1041. DOI: 10.12998/wjcc.v8.i6.1033.
|
[98] |
|
[99] |
Zhan Z, Han H, Zhao D, et al. Primary closure after laparoscopic common bile duct exploration is feasible for elderly patients: 5-Year experience at a single institution[J]. Asian J Surg, 2020, 43(1): 110-115. DOI: 10.1016/j.asjsur.2019.04.009.
|
[100] |
Wu X, Huang ZJ, Zhong JY, et al. Laparoscopic common bile duct exploration with primary closure is safe for management of choledocholithiasis in elderly patients[J]. Hepatobiliary Pancreat Dis Int, 2019, 18(6): 557-561. DOI: 10.1016/j.hbpd.2019.07.005.
|
[101] |
Yeon HJ, Moon JI, Lee SJ, et al. Is laparoscopic common bile duct exploration safe for the oldest old patients?[J]. Ann Geriatr Med Res, 2022, 26(2): 140-147. DOI: 10.4235/agmr.22.0026.
|
[102] |
Lee SE. One-stage versus two-stage approach for concomitant gallbladder and common bile duct stones: which one is more proper in patients over 80 years old?[J]. J Minim Invasive Surg, 2022, 25(1): 7-8. DOI: 10.7602/jmis.2022.25.1.7.
|
[103] |
|
[104] |
Miura F, Okamoto K, Takada T, et al. Tokyo Guidelines 2018: initial management of acute biliary infection and flowchart for acute cholangitis[J]. J Hepatobiliary Pancreat Sci, 2018, 25(1): 31-40. DOI: 10.1002/jhbp.509.
|
[105] |
|
[106] |
|
[107] |
|
[108] |
|
[109] |
|
[110] |
|